Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma.
about
Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas.c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients.Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers.Joint binding of OTX2 and MYC in promotor regions is associated with high gene expression in medulloblastoma.Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.Copy number gain of granulin-epithelin precursor (GEP) at chromosome 17q21 associates with overexpression in human liver cancer.Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: a report from the Children's Oncology GroupA contemporary review of molecular candidates for the development and treatment of childhood medulloblastoma.PVT1 dependence in cancer with MYC copy-number increase.Coagulation and angiogenic gene expression profiles are defined by molecular subgroups of medulloblastoma: evidence for growth factor-thrombin cross-talk.MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma.Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma.Prognostic significance of MYCN gene amplification and protein expression in primary brain tumors: Astrocytoma and meningioma.Biological and clinical heterogeneity of MYCN-amplified medulloblastoma.MicroRNA induction by copy number gain is associated with poor outcome in squamous cell carcinoma of the lung
P2860
Q33682954-1F9C969D-0F45-490F-AA38-CACFFDADE287Q33821504-D71E4496-61B6-41C3-8ADC-3A11B5D63DEFQ33886925-6CECD9D7-13B2-49CA-A292-B12822D10C09Q34053468-0960A5BA-9AAA-4B31-B648-71FC4AADE75BQ34580883-4C7EE04A-F0D4-4380-8A2C-6E6316BF2129Q35491733-5EA1EDC3-5828-43BB-9EA8-5A5D3B1711DEQ36010031-72DD4DB9-D2AC-4ABF-A060-8CA807A5CDA0Q38071943-67FF32D4-0FEC-40B2-AB01-9522D95FBC32Q38628939-A2C33512-692D-447E-ACFE-2034B0219D42Q38962343-AEBBC8B7-94D1-4074-BDF4-0A3E3E03A08DQ39679776-6495D6B3-A704-4C87-BA38-DCCDDF1ADB76Q43995999-AEE78FDC-936B-4889-8418-842D5A89CA45Q50692461-13F30C6D-DD48-4F0F-9D0C-0B570800AEE6Q55462417-105C336E-7DF7-43E6-88E4-AB5BE3255A75Q58603497-B0379068-60C7-4457-BC8A-198F92FC31C2
P2860
Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma.
@en
Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma.
@nl
type
label
Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma.
@en
Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma.
@nl
prefLabel
Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma.
@en
Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma.
@nl
P2093
P2860
P1476
Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma
@en
P2093
Dagmar Kantorova
Dita Zezulkova
Eva Necesalova
Hana Filkova
Iva Slamova
Jaroslav Sterba
Karel Zitterbart
Lenka Tomasikova
Martina Pesakova
P2860
P2888
P356
10.1007/S11060-010-0289-3
P577
2010-07-08T00:00:00Z
P6179
1016511546